OBJECTIVES: We investigated whether the presence of anemia is a risk factor for cardiovascular disease (CVD) outcomes in the general population. BACKGROUND: Chronic anemia is a risk factor for CVD outcomes in patients with kidney disease and in patients with heart failure, but has not been evaluated as a risk factor in the general population. METHODS: The Atherosclerosis Risk in Communities (ARIC) study was used to evaluate the relationship of anemia, defined by hemoglobin <13 g/dl in men and <12 g/dl in women, to CVD. Cox proportional hazards regression was used to adjust the relationship between anemia and CVD outcomes for other covariates in the entire study cohort, as well as in subgroups of men, women, African Americans and whites. RESULTS: A total of 14,410 subjects (6,267 men and 8,143 women) without CVD at baseline had hemoglobin levels measured. Three hundred men (4.8%) and 1,058 women (13.0%) were anemic. During an average follow-up of 6.1 years there was a total of 549 (3.8%) CVD events. The presence of anemia was independently associated with an increased risk of CVD (hazard ratio [95% confidence interval] of 1.41 [1.01, 1.95]) in the entire study cohort. In subgroup analyses the hazard ratios were in the same direction, although not statistically significant in all cases. CONCLUSIONS: Anemia is an independent risk factor for CVD outcomes in the ARIC cohort, a community cohort of subjects between the ages of 45 and 64 years.
OBJECTIVES: We investigated whether the presence of anemia is a risk factor for cardiovascular disease (CVD) outcomes in the general population. BACKGROUND:Chronic anemia is a risk factor for CVD outcomes in patients with kidney disease and in patients with heart failure, but has not been evaluated as a risk factor in the general population. METHODS: The Atherosclerosis Risk in Communities (ARIC) study was used to evaluate the relationship of anemia, defined by hemoglobin <13 g/dl in men and <12 g/dl in women, to CVD. Cox proportional hazards regression was used to adjust the relationship between anemia and CVD outcomes for other covariates in the entire study cohort, as well as in subgroups of men, women, African Americans and whites. RESULTS: A total of 14,410 subjects (6,267 men and 8,143 women) without CVD at baseline had hemoglobin levels measured. Three hundred men (4.8%) and 1,058 women (13.0%) were anemic. During an average follow-up of 6.1 years there was a total of 549 (3.8%) CVD events. The presence of anemia was independently associated with an increased risk of CVD (hazard ratio [95% confidence interval] of 1.41 [1.01, 1.95]) in the entire study cohort. In subgroup analyses the hazard ratios were in the same direction, although not statistically significant in all cases. CONCLUSIONS:Anemia is an independent risk factor for CVD outcomes in the ARIC cohort, a community cohort of subjects between the ages of 45 and 64 years.
Authors: Ana de Lurdes Agostinho Cabrita; Ana Pinho; Anabela Malho; Elsa Morgado; Marília Faísca; Hermínio Carrasqueira; Ana Paula Silva; Pedro Leão Neves Journal: Int Urol Nephrol Date: 2010-07-17 Impact factor: 2.370
Authors: Ellen M Smith; Jessica A Alvarez; Greg S Martin; Susu M Zughaier; Thomas R Ziegler; Vin Tangpricha Journal: Br J Nutr Date: 2015-04-16 Impact factor: 3.718
Authors: L Jørgensen; T Skjelbakken; M-L Løchen; L Ahmed; A Bjørnerem; R Joakimsen; B K Jacobsen Journal: Osteoporos Int Date: 2009-12-03 Impact factor: 4.507
Authors: Minerva Rodríguez-García; Carlos Gómez-Alonso; Manuel Naves-Díaz; Jose Bernardino Diaz-Lopez; Carmen Diaz-Corte; Jorge B Cannata-Andía Journal: Nephrol Dial Transplant Date: 2008-08-25 Impact factor: 5.992
Authors: Santhi K Ganesh; Neil A Zakai; Frank J A van Rooij; Nicole Soranzo; Albert V Smith; Michael A Nalls; Ming-Huei Chen; Anna Kottgen; Nicole L Glazer; Abbas Dehghan; Brigitte Kuhnel; Thor Aspelund; Qiong Yang; Toshiko Tanaka; Andrew Jaffe; Joshua C M Bis; Germaine C Verwoert; Alexander Teumer; Caroline S Fox; Jack M Guralnik; Georg B Ehret; Kenneth Rice; Janine F Felix; Augusto Rendon; Gudny Eiriksdottir; Daniel Levy; Kushang V Patel; Eric Boerwinkle; Jerome I Rotter; Albert Hofman; Jennifer G Sambrook; Dena G Hernandez; Gang Zheng; Stefania Bandinelli; Andrew B Singleton; Josef Coresh; Thomas Lumley; André G Uitterlinden; Janine M Vangils; Lenore J Launer; L Adrienne Cupples; Ben A Oostra; Jaap-Jan Zwaginga; Willem H Ouwehand; Swee-Lay Thein; Christa Meisinger; Panos Deloukas; Matthias Nauck; Tim D Spector; Christian Gieger; Vilmundur Gudnason; Cornelia M van Duijn; Bruce M Psaty; Luigi Ferrucci; Aravinda Chakravarti; Andreas Greinacher; Christopher J O'Donnell; Jacqueline C M Witteman; Susan Furth; Mary Cushman; Tamara B Harris; Jing-Ping Lin Journal: Nat Genet Date: 2009-10-11 Impact factor: 38.330